Literature DB >> 1182653

Fetal mesenchymal hamartoma of kidney. A tumor of secondary mesenchyme.

H J Wigger.   

Abstract

The ultrastructure of a fetal mesenchymal hamartoma of the kidney shows undifferentiated mesenchymal cells, whose morphological characteristics conform to those of secondary mesenchyme. In contrast to primary mesenchyme or mesoblast, which may form epithelial structures, secondary mesenchyme is incapable of doing so. While Wilms' tumor may be considered a tumor of mesoblast, the fetal mesenchymal hamartoma is believed to originate from secondary mesenchyme or some of its more mature derivatives.

Entities:  

Mesh:

Year:  1975        PMID: 1182653     DOI: 10.1002/1097-0142(197509)36:3<1002::aid-cncr2820360324>3.0.co;2-3

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  5 in total

1.  Fibrous histiocytoma simulating congenital fibromatosis: a light-, electron microscopic and tissue culture study.

Authors:  H J Wigger; S M Mitsudo
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1976-06-22

2.  Morphological and immunohistochemical characteristics of dimethylnitrosamine-induced malignant mesenchymal renal tumor in F-344 rats.

Authors:  B Dezso; P Rady; I Morocz; E Varga; S Gomba; K Poulsen; P Kertai
Journal:  J Cancer Res Clin Oncol       Date:  1990       Impact factor: 4.553

3.  Mixed epithelial and stromal tumors of the kidney. A report of 22 cases.

Authors:  Michal Michal; Ondrej Hes; Michele Bisceglia; Roderick H W Simpson; Dominic V Spagnolo; Alberto Parma; Ludmila Boudova; Milan Hora; Roman Zachoval; Saul Suster
Journal:  Virchows Arch       Date:  2004-08-20       Impact factor: 4.064

4.  Chromosome aberrations in mesoblastic nephroma.

Authors:  D E Schofield; E J Yunis; J A Fletcher
Journal:  Am J Pathol       Date:  1993-09       Impact factor: 4.307

5.  Mesoblastic nephroma of infancy.

Authors:  Jyotsna Sen; Rajeev Sen; Kamal Rattan; Sumiti Gupta; Indu Bansal; B Arora
Journal:  Indian J Pediatr       Date:  2004-02       Impact factor: 1.967

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.